TP53 and melanoma: The procedure showed that, in datasets GSE7553 and GSE15605, melanoma samples (Fig. 6B,E) have greater variability than nontumor ones (Fig. 6A,D), as they include a fraction (13% and 24%) of samples with impaired response to p53, as indicated by their reduced line slope.